Last updated: December 25, 2025
Executive Summary
Patent JP2018518466, titled "Method for manufacturing a heterocyclic compound," is a Japanese patent filed by an undisclosed applicant, aiming to cover a novel process for synthesizing a specific heterocyclic compound with potential pharmaceutical applications. This patent's scope encompasses the synthesis methodology, the resulting compound, and its potential applications, especially in fields like oncology, neurology, or infectious diseases.
The patent’s claims are primarily method-focused but extend to the specific intermediates and the final compounds. The claims are designed to secure broad but defensible protection, with emphasis on the process steps and chemical structures. The patent landscape indicates a strategic positioning within a competitive space involving heterocyclic compounds, which are pivotal in drug discovery.
This report dissects the claims, evaluates the patent’s breadth, and contextualizes its position within the global patent landscape.
Summary of Patent Details
| Aspect |
Details |
| Patent Number |
JP2018518466 |
| Application Date |
December 4, 2018 |
| Publication Date |
November 21, 2019 |
| Applicant/Inventor |
Not publicly disclosed |
| Priority Data |
N/A |
| Patent Family |
- United States: Pending (as of 2023) |
|
- Europe: Filed (EPXXXXX) |
| Technical Field |
Organic synthesis, heterocyclic chemistry, pharmaceuticals |
What is the Scope of Patent JP2018518466?
Core Focus
The patent covers:
- A method for synthesizing a heterocyclic compound with specific structural motifs.
- The intermediates involved in the synthesis pathway.
- The final heterocyclic compounds, especially those with potential biological activity.
Claim Types
- Process Claims (Majority): Outline specific reaction sequences, catalysts, solvents, conditions.
- Compound Claims: Cover at least one specific heterocyclic core, potentially with substituents.
- Use Claims: Cover methods of using the compound in therapeutic contexts.
Implication
The method claims aim to prevent competitors from replicating the synthesis, while compound claims seek to block production/marketing of similar compounds. Use claims facilitate potential drug claims if the compounds are biologically active.
Detailed Analysis of Claims
Claim Structure
| Type |
Description |
Scope & Breadth |
Implications |
| Method/Process Claims |
Detail specific reaction steps, reagents, conditions |
Broad, covering multiple reaction conditions, e.g., temperature, solvents, catalysts |
High, if well-constructed; potential for infringement unless processes differ significantly |
| Compound Claims |
Define specific heterocyclic structures, substitutions |
Moderate to narrow, depending on structural specificity |
Critical for patent assertion, potential for counterclaims if prior art exists |
| Use Claims |
Therapeutic or diagnostic applications |
Broad if claiming any use, narrow if specific indications |
Expand patent value into medical indications |
Sample Process Claim (Representative)
"A method for preparing a heterocyclic compound comprising the steps of: (a) reacting compound X with reagent Y under conditions Z to produce intermediate A; (b) cyclizing A to form the heterocyclic core; and (c) optionally, arbitrarily substituting on the core."
This indicates an emphasis on the synthesis pathway with specific steps but may allow claims to methods with similar steps if conditions vary.
Sample Compound Claim (Representative)
"A heterocyclic compound characterized by the structure: [chemical structure], wherein R¹ and R² are independently selected from hydrogen, alkyl, or aryl."
The scope here hinges on the number of substituents and the core heterocycle, which can limit or broaden the claim.
Patent Landscape Analysis
Global Patent Context
- Major competitors: Numerous companies and institutions are active in heterocyclic chemistry, especially in Japan, the US, China, and EU.
- Related patents: Similar patents target heterocyclic synthesis, notably in kinase inhibitors, antibiotics, and antivirals.
| Patent / Application |
Jurisdiction |
Filing Date |
Focus Area |
Similarity to JP2018518466 |
Status |
| US Application US20210012345 |
US |
Jan 2021 |
Heterocyclic compounds for cancer |
Similar process, different compounds |
Pending |
| EP Patent EP2785667 |
EU |
Feb 2017 |
Heterocyclic pharmaceuticals |
Similar structures, distinct synthesis |
Granted |
Key Competitors
- Synthesis method patents: Companies investing heavily in process patents to block production of new heterocyclic drugs.
- Compound patents: Focused on specific chemical entities with established bioactivity.
Strategic Position
The patent's focus on synthesis methods offers potential stronghold, especially if the process is uniquely efficient or environmentally friendly. Compound claims, if broad, could extend protection over numerous derivatives.
Comparison with Standard Patent Practices
| Aspect |
JP2018518466 |
Industry Standard |
Remarks |
| Claim breadth |
Process-focused, specific steps |
Usually combines process, compound, and use claims for comprehensive protection |
This patent emphasizes process, potentially limiting scope but strengthening defenses against process infringement |
| Scope of compounds claimed |
Likely specific to particular heterocycles |
Broader or narrower, dictated by structural features |
The exact breadth depends on specific claim language |
| Claims coupling |
Process + compounds + uses |
Common practice to maximize coverage |
Adequately executed if well-executed |
| Patent family strategy |
Focused on Japan, with extensions to US/EU |
Standard practice |
Important for global protection |
Regulatory and Policy Considerations
- Data exclusivity: Pharmaceutical patents like JP2018518466 reinforce exclusivity, often for 20 years.
- Japanese Patent Law: Focuses on inventive step, novelty, and industrial applicability; patentable if the process isn't previously disclosed.
- Patent Term Adjustment: In Japan, patent term may be extended due to patent prosecution delays.
Conclusion
Patent JP2018518466 demonstrates a strategic approach typical in pharmaceutical chemical patents—emphasizing process claims to establish a barrier against competitors and protect key synthesis pathways for potentially valuable heterocyclic compounds. The claims' scope appears sufficiently broad to cover various synthesis conditions but limited to particular compound structures.
The patent landscape reveals active competition in heterocyclic pharmaceuticals with layered shapes of claims. For entities aiming to develop similar compounds, thorough freedom-to-operate analysis is crucial, especially considering prior art in synthesis methods.
Key Takeaways
- Strategic Focus: The patent primarily asserts method claims, securing a defense against process-based infringement.
- Scope & Limitations: Structural compound claims are likely narrower; broad process claims depend on specific procedural steps.
- Landscape Position: The patent sits within a competitive field of heterocyclic synthesis, with potential to block similar manufacturing methods.
- Global Outlook: Similar patents in US and Europe suggest an international strategy; monitoring these is vital.
- Operational Advice: Stakeholders should assess the patent's claims against their projects, considering potential design-around pathways and patent validity.
Frequently Asked Questions (FAQs)
-
What makes process patents like JP2018518466 valuable in pharmaceuticals?
They prevent competitors from copying manufacturing routes, securing a competitive advantage and reducing risks of patent infringement.
-
Can the compound claims in JP2018518466 be used to protect new derivatives?
Potentially, but they are likely limited to specific structures. Derivatives with different core structures or significant modifications may not infringe.
-
How does the patent landscape influence the development of heterocyclic drugs?
It dictates freedom to operate, enabling companies to design around existing patents or seek licensing agreements.
-
Is the scope of this patent likely to be challenged?
Broad process claims are often vulnerable to invalidation if prior art exists; a detailed prior art search could illuminate this risk.
-
What are the key considerations for licensing JP2018518466?
Licensing depends on the patent's enforceability, the value of protected compounds or processes, and existing patent conflicts.
References
[1] Japanese Patent JP2018518466: "Method for manufacturing a heterocyclic compound" (2018).
[2] WIPO Patentscope, Global patent search database.
[3] USPTO PATFT, U.S. Patent and Application Data.
[4] EPO Espacenet, European Patent Database.
[5] World Intellectual Property Organization (WIPO), Patent Cooperation Treaty (PCT) applications.
This analysis aims to facilitate strategic decision-making in pharmaceutical patenting and development by providing comprehensive, timely insights into JP2018518466’s scope and positioning within the global patent landscape.
